ProfileGDS4718 / 218989_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 88% 83% 90% 92% 89% 91% 90% 91% 92% 94% 88% 92% 91% 90% 94% 94% 87% 91% 71% 91% 91% 93% 92% 92% 89% 92% 84% 89% 90% 91% 88% 87% 93% 91% 93% 85% 90% 90% 87% 91% 90% 88% 88% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.6191592
GSM549102patient 115, normal, homogenized [OPG study]8.8839688
GSM549104patient 119, normal, homogenized [OPG study]8.271683
GSM549108patient 138, normal, homogenized [OPG study]9.103490
GSM549119patient 077, normal, homogenized [OPG study]9.6103292
GSM549133patient 032, cancer, homogenized [OPG study]9.1722389
GSM549139patient 042, cancer, homogenized [OPG study]9.3452791
GSM549099patient 107, normal, homogenized [OPG study]9.2052590
GSM549109patient 139, normal, homogenized [OPG study]9.3613191
GSM549110patient 046, normal, homogenized [OPG study]9.6167292
GSM549114patient 063, normal, homogenized [OPG study]10.066694
GSM549122patient 082, normal, homogenized [OPG study]8.9316388
GSM549134patient 033, cancer, homogenized [OPG study]9.5096692
GSM549136patient 036, cancer, homogenized [OPG study]9.4517891
GSM549140patient 044, cancer, homogenized [OPG study]9.2781190
GSM549111patient 047, normal, homogenized [OPG study]10.102594
GSM549113patient 057, normal, homogenized [OPG study]10.090194
GSM549132patient 031, cancer, homogenized [OPG study]8.7778387
GSM549137patient 038, cancer, homogenized [OPG study]9.3478791
GSM549142patient 047, cancer, homogenized [OPG study]6.8841571
GSM549100patient 110, normal, homogenized [OPG study]9.3518691
GSM549107patient 135, normal, homogenized [OPG study]9.4703191
GSM549115patient 068, normal, homogenized [OPG study]9.9145693
GSM549116patient 072, normal, homogenized [OPG study]9.7461592
GSM549120patient 078, normal, homogenized [OPG study]9.5201392
GSM549131patient 030, cancer, homogenized [OPG study]9.1397389
GSM549118patient 074, normal, homogenized [OPG study]9.6014792
GSM549129patient 027, cancer, homogenized [OPG study]8.3448484
GSM549123patient 088, normal, homogenized [OPG study]9.1483389
GSM549124patient 006, cancer, homogenized [OPG study]9.1002890
GSM549126patient 015, cancer, homogenized [OPG study]9.3879491
GSM549128patient 025, cancer, homogenized [OPG study]8.9349688
GSM549103patient 117, normal, homogenized [OPG study]8.6833187
GSM549117patient 073, normal, homogenized [OPG study]9.8911993
GSM549138patient 041, cancer, homogenized [OPG study]9.3963791
GSM549141patient 045, cancer, homogenized [OPG study]9.8668693
GSM549130patient 028, cancer, homogenized [OPG study]8.40685
GSM549101patient 111, normal, homogenized [OPG study]9.1619690
GSM549105patient 128, normal, homogenized [OPG study]9.095390
GSM549106patient 134, normal, homogenized [OPG study]8.9613787
GSM549112patient 048, normal, homogenized [OPG study]9.4258591
GSM549125patient 011, cancer, homogenized [OPG study]9.1713190
GSM549127patient 024, cancer, homogenized [OPG study]8.8479988
GSM549135patient 035, cancer, homogenized [OPG study]8.9553988